| | | |
ULC therapy
| |
RFVE therapy
|
|---|
| | |
n
|
Before
|
After
|
n
|
Before
|
After
|
|---|
|
Overall
| |
113
|
41.1 ± 17.6
|
44.1 ± 17.3*
|
263
|
41.7 ± 16.1
|
48.2 ± 15.2*†
|
|
Motor impairment
|
F-M UE score ≤ 20
|
19
|
11.1 ± 6.5
|
14.6 ± 8.5*
|
35
|
11.8 ± 5.2
|
19.0 ± 9.0*†
|
|
21 ≤ F-M UE score ≤ 40
|
29
|
32.5 ± 5.5
|
36.1 ± 6.8*
|
72
|
32.2 ± 5.9
|
41.5 ± 7.6*†
|
|
F-M UE score > 40
|
65
|
53.8 ± 7.1
|
55.9 ± 8.1*
|
156
|
52.7 ± 7.3
|
57.8 ± 6.4*†
|
|
Stroke to Rehabilitation Interval
|
≤ 3months
|
32
|
47.7 ±16.4
|
51.3 ± 15.2*
|
68
|
44.9 ± 14.0
|
53.8 ± 11.5*†
|
|
3 < months < 12
|
57
|
38.9 ± 17.5
|
41.7 ± 17.2*
|
113
|
39.5 ± 17.2
|
46.0 ± 16.0*†
|
|
≥ 12 months
|
24
|
37.7 ± 17.7
|
40.3 ± 18.0*
|
82
|
41.8 ± 15.9
|
46.7 ± 15.7*
|
- Data are presented as mean ± SD. n number of patients, ULC Upper Limb Conventional, RFVE Reinforced Feedback in Virtual Environment, F-M UE Fugl – Meyer Upper Extremity.
- * p ≤ 0.05 within group analysis (Wilcoxon test).
- † p ≤ 0.05 between group analysis (Mann–Whitney U test).
